Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+ CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects

被引:231
作者
Long, S. Alice [1 ]
Cerosaletti, Karen [1 ]
Bollyky, Paul L. [1 ]
Tatum, Megan [1 ]
Shilling, Heather [1 ]
Zhang, Sheng [2 ]
Zhang, Zhong-Yin [2 ]
Pihoker, Catherine [3 ]
Sanda, Srinath [1 ]
Greenbaum, Carla [1 ]
Buckner, Jane H. [1 ]
机构
[1] Benaroya Res Inst Virginia Mason, Seattle, WA USA
[2] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA
[3] Seattle Childrens Hosp, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
PROTEIN-TYROSINE-PHOSPHATASE; INTERLEUKIN-2; ACTIVATION; RECEPTOR; EFFECTOR; BETA; MICE; DEMETHYLATION; FREQUENCY; EXPANSION;
D O I
10.2337/db09-0694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-In humans, multiple genes in the interleukin (IL)-2/IL-2 receptor (IL-2R) pathway are associated with type 1 diabetes. However, no link between IL-2 responsiveness and CD4(+)CD25(+)FOXP3(+) regulatory T-cells (Tregs) has been demonstrated in type 1 diabetic subjects despite the role of these IL-2-dependent cells in controlling autoimmunity. Here, we address whether altered IL-2 responsiveness impacts persistence of FOXP3 expression in Tregs of type 1 diabetic subjects. RESEARCH DESIGN AND METHODS-Persistence of Tregs was assessed by culturing sorted CD4(+)CD25(hi) natural Tregs with IL-2 and measuring FOXP3 expression over time by (low cytometry for control and type 1 diabetic populations. The effects of IL-2 on FOXP3 induction were assessed 48 h after activation of CD4(+)CD25(-) T-cells with anti-CD3 antibody. Cytokine receptor expression and signaling upon exposure to IL-2, IL-7, and IL-15 were determined by flow cytometry and Western blot analysis. RESULTS-Maintenance of FOXP3 expression in CD4(+)CD25(+) Tregs of type 1 diabetic subjects was diminished in the presence of IL-2, but not IL-7. Impaired responsiveness was not linked to altered expression of the IL-2R complex. Instead, IL-2R signaling was reduced in Tregs and total CD4(+) T-cells of type 1 diabetic subjects. In some individuals, decreased signal transducer and activator of transcription 5 phosphorylation correlated with significantly higher expression of protein tyrosine phosphatase N2, a negative regulator of IL-2R signaling. CONCLUSIONS-Aberrant IL-2R signaling in CD4(+) T-cells of type 1 diabetic subjects contributes to decreased persistence of FOXP3 expression that may impact establishment of tolerance. These findings suggest novel targets for treatment: of type 1 diabetes within the IL-2R pathway and suggest that an altered IL-2R signaling signature may be a biomarker for type 1 diabetes. Diabetes 59:407-415, 2010
引用
收藏
页码:407 / 415
页数:9
相关论文
共 50 条
[1]   NOD mice and autoimmunity [J].
Aoki, CA ;
Borchers, AT ;
Ridgway, WM ;
Keen, CL ;
Ansari, AA ;
Gershwin, ME .
AUTOIMMUNITY REVIEWS, 2005, 4 (06) :373-379
[2]   IL-2 receptor alpha deficiency and features of primary biliary cirrhosis [J].
Aoki, Christopher A. ;
Roifman, Chaim M. ;
Lian, Zhe-Xiong ;
Bowlus, Christopher L. ;
Norman, Gary L. ;
Shoenfeld, Yehuda ;
Mackay, Ian R. ;
Gershwin, M. Eric .
JOURNAL OF AUTOIMMUNITY, 2006, 27 (01) :50-53
[3]   DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells [J].
Baron, Udo ;
Floess, Stefan ;
Wieczorek, Georg ;
Baumann, Katrin ;
Gruetzkau, Andreas ;
Dong, Jun ;
Thiel, Andreas ;
Boeld, Tina J. ;
Hoffmann, Petra ;
Edinger, Matthias ;
Tuerbachova, Ivana ;
Hamann, Alf ;
Olek, Sven ;
Huehn, Jochen .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (09) :2378-2389
[4]   A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells [J].
Bayer, Allison L. ;
Lee, Joon Youb ;
de la Barrera, Anabel ;
Surh, Charles D. ;
Malek, Thomas R. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (01) :225-234
[5]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[6]   Functional defects and the influence of age on the frequency of CD4+CD25+ T-Cells in type 1 diabetes [J].
Brusko, TM ;
Wasserfall, CH ;
Clare-Salzler, MJ ;
Schatz, DA ;
Atkinson, MA .
DIABETES, 2005, 54 (05) :1407-1414
[7]   No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes [J].
Brusko, Todd ;
Wasserfall, Clive ;
McGrail, Kieran ;
Schatz, Richard ;
Viener, Hina Lee ;
Schatz, Desmond ;
Haller, Michael ;
Rockell, Jennifer ;
Gottlieb, Peter ;
Clare-Salzler, Michael ;
Atkinson, Mark .
DIABETES, 2007, 56 (03) :604-612
[8]   Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire [J].
Burchill, Matthew A. ;
Yang, Jianying ;
Vang, Kieng B. ;
Moon, James J. ;
Chu, H. Hamlet ;
Lio, Chan-Wang J. ;
Vegoe, Amanda L. ;
Hsieh, Chyi-Song ;
Jenkins, Marc K. ;
Farrar, Michael A. .
IMMUNITY, 2008, 28 (01) :112-121
[9]   Interleukin-2 receptor signaling in regulatory T cell development and homeostasis [J].
Burchill, Matthew A. ;
Yang, Jianying ;
Vang, Kieng B. ;
Farrar, Michael A. .
IMMUNOLOGY LETTERS, 2007, 114 (01) :1-8
[10]   IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells [J].
Burchill, Matthew A. ;
Yang, Jianying ;
Vogtenhuber, Christine ;
Blazar, Bruce R. ;
Farrar, Michael A. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (01) :280-290